Contribution to study the glycoprotein ligands of the cerebellar soluble lectin in human K562 tumour cells

Many cancer cells over-express significantly the glycoproteins specific to the endogenous cerebellar soluble lectin or CSL. These ligands may present the same electrophoretic profiles regardless of the specie or tissue. We purified a large amount of the active CSL using an immuno-affinity chromatography, which was used to isolate the CSL ligands from human tumour K562 cell lines. After protease digestion of these ligands, we analyzed the obtained peptides using reverse phase chromatography and isolated an overrepresented group that carried N-glycans and was relatively hydrophobic. Thus, we suggested that the CSL ligands have a common pepetide sequence specifically recognized by the CSL, who could direct the production of these CSL-recognized N-glycans. Moreover, we speculated that the expression deregulation of a specific exon encoding this peptide sequence alters the glycosylation in K562 tumour cells.Keywords: CSL; glycoprotein ligands; tumour K562 cells; N-glycosylation; peptide signa

Retrospective study of epidemiological, clinicopathological and biological profils of 62 colorectal cancers cases in Jijel provence (Algeria)

In Algeria, the CRC wing and become the first digestive cancer in both sexes,  outperforming stomach cancer. To enrich the Algerian cancer registries, we analyzed the profiles of patients with these cancers in Jijel Willaya. This was a retrospective and descriptive analysis of epidemiological, clinicopathological and biological profiles of 62 CRC cases. We found that the CRC represented the first type of digestive cancers in which the three quarters were colon cancers. The most affected age group was 60-70 years with a male predominance and an average age of 56.20 years. The bleeding and abdominal pain were the majority telltale signs. The combined chemotherapy has been standardized with all patients and the Lieberkühnien adenocarcinoma was the major histological form. The disease issue and the choice of therapy depended on the K-RAS gene mutations. Our results were often compatible with the available literature and may provide reliable and relevant data on this disease.Key words: Colorectal cancer; Epidemiology; Therapy; Adenocarcinoma; K-RAS gen

Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC(Min/+) Mouse Model of Intestinal Tumorigenesis

Canadian Institutes of Health Research grant to JL

Circulating galectins-2,-4 and-8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis

BACKGROUND: Circulating concentrations of the cytokines interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF) and chemokines monocyte chemotatic protein 1 (MCP-1)/CCL2 and growth-regulator oncogene α (GROα)/chemokine C-X-C motif ligand 1 are commonly increased in cancer patients and they are increasingly recognised as important promoters, via divergent mechanisms, of cancer progression and metastasis. METHODS: The effect of galectins-2, -4 and -8, whose circulating levels are highly increased in cancer patients, on endothelial secretion of cytokines was assessed in vitro by cytokine array and in mice. The relationship between serum levels of galectins and cytokines was analysed in colon and breast cancer patients. RESULTS: Galectins-2, -4 and -8 at pathological concentrations induce secretion of G-CSF, IL-6, MCP-1 and GROα from the blood vascular endothelial cells in vitro and in mice. Multiple regression analysis indicates that increased circulation of these galectins accounts for 41∼83% of the variance of these cytokines in the sera of colon and breast cancer patients. The galectin-induced secretion of these cytokines/chemokines is shown to enhance the expression of endothelial cell surface adhesion molecules, causing increased cancer-endothelial adhesion and increased endothelial tubule formation. CONCLUSION: The increased circulation of galectins -2, -4 and -8 in cancer patients contributes substantially to the increased circulation of G-CSF, IL-6 and MCP-1 by interaction with the blood vascular endothelium. These cytokines and chemokines in turn enhance endothelial cell activities in angiogenesis and metastasis